(E)-3-((5-(4-Chlorostyryl)-1,2,4-oxadiazol-3-yl)methyl)pyrido[2,3-d]pyrimidin-4(3H)-one

ID: ALA3787029

Chembl Id: CHEMBL3787029

PubChem CID: 127034466

Max Phase: Preclinical

Molecular Formula: C18H12ClN5O2

Molecular Weight: 365.78

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1c2cccnc2ncn1Cc1noc(/C=C/c2ccc(Cl)cc2)n1

Standard InChI:  InChI=1S/C18H12ClN5O2/c19-13-6-3-12(4-7-13)5-8-16-22-15(23-26-16)10-24-11-21-17-14(18(24)25)2-1-9-20-17/h1-9,11H,10H2/b8-5+

Standard InChI Key:  FNDVNJLIBJSDBE-VMPITWQZSA-N

Alternative Forms

  1. Parent:

    ALA3787029

    ---

Associated Targets(Human)

TRPA1 Tclin Transient receptor potential cation channel subfamily A member 1 (1847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trpa1 Transient receptor potential cation channel subfamily A member 1 (1003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 365.78Molecular Weight (Monoisotopic): 365.0680AlogP: 3.05#Rotatable Bonds: 4
Polar Surface Area: 86.70Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.00CX LogP: 3.59CX LogD: 3.59
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.55Np Likeness Score: -1.41

References

1. Schenkel LB, Olivieri PR, Boezio AA, Deak HL, Emkey R, Graceffa RF, Gunaydin H, Guzman-Perez A, Lee JH, Teffera Y, Wang W, Youngblood BD, Yu VL, Zhang M, Gavva NR, Lehto SG, Geuns-Meyer S..  (2016)  Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.,  59  (6): [PMID:26942860] [10.1021/acs.jmedchem.6b00039]

Source